CONNECT WITH US:
Jun, 12 2019 15:00 JST
Singapore eDevelopment Ltd
Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing
SINGAPORE, Jun, 12 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd (SeD; SGX:40V) wishes to announce that its U.S. biomedical subsidiary, Global BioLife Inc., has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight (8) hours.
In 2017, SeD announced a collaboration between Global BioLife and U.S. based Chemia Corporation to develop a suite of fragrances referred to as 3F (Functional Fragrance Formulation). Previous testing was promising for the 3F Mosquito Fragrance, which is made of specialised oils sourced from botanicals that mosquitoes avoid in varying concentrations of 0.25% to 5%.
Global BioLife contracted U.S. based Snell Scientifics, LLC in Meansville, Georgia to conduct a study on the new mosquito repellent formula and the results of the study showed that it repelled between 82% to 95% of mosquitos for six (6) hours after application.
"Utilising fragrances to repel mosquitos with this level of efficacy is a game changer for the consumer products industry," said Mr. Thomas A. Meyer, Chemia's Vice-President of Innovation and Sustainability.
Globally, an estimated 3.4 billion people in 92 countries are at risk of being infected with Zika, Dengue, West Nile Virus, Malaria and other mosquito transmitted diseases. Mosquito repellent products are key in the fight against mosquito transmitted diseases, while a product favoured by consumers is easy to apply, is considered safe, and does not have unpleasant attributes such as a strong chemical odour.
The market for safe mosquito repellents is expanding, and consumers have expressed a demand for effective mosquito repellent products with appealing scents. The most recently tested product has a fragrance that is modeled on the fresh scent of the Ghost Orchid, a rare flower known for its distinctive and pleasant aroma found in the Everglades of Florida.
"3F Mosquito works differently from traditional insect repellents. It's effective even at very low concentrations due to its multi-aspect receptor inhibition," said Mr. Daryl Thompson, Global BioLife's Director of Scientific Initiatives.
"Global BioLife is extremely proud of these test results," said SeD's Executive Chairman Mr. Chan Heng Fai. "3F is an innovative product that works in an entirely different manner from any other product on the market today. 3F is a true success for people everywhere and will help reduce the number of mosquito transmitted diseases on a global scale."
Global BioLife is currently in discussions with interested companies for potential licensing and global deployment of this new mosquito repellent formula.
About Singapore eDevelopment Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email
About Global BioLife Inc.
Global BioLife Inc. ("GBLI") is a 70%-held direct subsidiary of Global BioMedical Inc., which is a wholly-owned direct subsidiary of Singapore BioMedical Pte. Ltd., which in turn is a wholly-owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. The remaining shareholding of Global BioLife Inc. is held by Global Research and Discovery Group Scientific LLC ("GRDGS") at 20% and Australian Exchange-listed Holista CollTech Limited ("Holista") at 10%. For more information, please visit:
About GRDG Sciences, LLC.
GRDG Sciences, LLC is an advanced research team formed in Florida by natural products discovery drug research scientist, Daryl Thompson. For more information, please visit:
Source: Singapore eDevelopment Ltd
Sectors: HealthCare, Cosmetics/Spec.Chem
Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Toyota Announces Board Member, Executive, Organizational, and Personnel Changes
Jun 13, 2019 16:08 JST
Mitsubishi Motors: Eclipse Cross diesel engine version launch in Japan
Jun 13, 2019 15:08 JST
Sharp Builds Mega Solar Plant near New Ulaanbaatar International Airport, Mongolia
Jun 13, 2019 12:10 JST
NEC Introduces Unique, Adaptive Energy Warranty to Optimize Value for Energy Storage Customers
Jun 13, 2019 11:21 JST
Mitsubishi Corporation and Komeda Agree to Business Alliance and Acquisition of Third Party Shares
Jun 12, 2019 15:01 JST
MHPS to Participate in G20 Innovation Exhibition
Jun 12, 2019 11:10 JST
TOYOTA GAZOO Racing Takes on the Challenge of 24 Hours of Nurburgring Endurance Race with New GR Supra and Second-Year Lexus LC
Jun 11, 2019 17:09 JST
Fujitsu Expands Initiative to Resolve Ocean Plastic Waste Problem
Jun 11, 2019 11:10 JST
NEC and Aviat Sign Channel Partner Agreement for North America Microwave Business
Jun 11, 2019 11:00 JST
DENSO, Honeywell Partnership Takes Off to Create Electric Propulsion Systems for Urban Air Mobility
Jun 11, 2019 05:07 JST
NEC Provides TOP500 Supercomputer to RWTH Aachen University in Germany
Jun 10, 2019 17:05 JST
MHI Conducts Running Test of Explosion-Proof Plant Inspection Robot EX ROVR
Jun 10, 2019 11:36 JST
TOYOTA GAZOO Racing Ready to Defend Le Mans Crown
Jun 07, 2019 17:04 JST
Toyota: Aiming to Popularize BEVs
Jun 07, 2019 13:28 JST
Showa Denko Group Recycles 4.79 Million Aluminum Cans in FY2018
Jun 06, 2019 14:30 JST
Toyota and Subaru Agree to Jointly Develop BEV-dedicated Platform and BEV SUV
Jun 06, 2019 14:04 JST
MHPS Ships Gas Turbine for 500 MW Natural-gas-fired GTCC Power Generation System in Indonesia
Jun 06, 2019 13:53 JST
Gavi, NEC, and Simprints to Deploy World's First Scalable Child Fingerprint Identification Solution to Boost Immunization in Developing Countries
Jun 06, 2019 11:00 JST
Mitsubishi Motors Celebrates a Decade of i-MiEV, Pioneering Mass-Production Electric Vehicles
Jun 05, 2019 15:18 JST
WorkFusion and NEC Partner to Bring AI-driven Robotic Process Automation to Global Markets
Jun 05, 2019 15:17 JST
More Latest Release >>
Singapore eDevelopment subsidiary Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
January 28 2019 12:00 JST
Singapore eDevelopment Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018
November 07 2018 19:00 JST
Singapore eDevelopment Announces Corporate and Business Update
June 18 2018 19:00 JST
Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar
May 31 2018 18:00 JST
Singapore eDevelopment biomedical subsidiary confirms LB2 efficacy against Ebola
March 01 2018 14:00 JST
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
November 01 2017 18:00 JST
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
October 24 2017 18:00 JST
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases
August 15 2017 19:00 JST
First-Year Performance of Global Systematic Multi-Strategy Fund
June 15 2017 10:15 JST
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
May 22 2017 11:00 JST
More Press release >>